(Press-News.org) D'Or Institute for Research and Education (IDOR) played an important role in the phase III LIBRETTO-431 multicenter study, which evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune checkpoint inhibitor) in non-small cell lung cancer (NSCLC). The research was published in the New England Journal of Medicine (NEJM), one of the most important scientific publications in the medical field, and included Dr. Milena Perez Mak, IDOR researcher and clinical oncologist at the São Paulo State Cancer Institute (Icesp).
Lung cancer is one of the most common cancers worldwide and is notable for its high lethality. Among the subtypes of lung cancer, NSCLC is the most common, accounting for approximately 85% of cases. It originates in the cells of the bronchi and alveoli of the lungs.
The study evaluated the efficacy of selpercatinib in patients with NSCLC who had genomic alterations in the RET gene. The therapy in question was based on a RET inhibitor, the aim of which is to block the action of the abnormal gene responsible for the proliferation of cancer cells. Combining chemotherapy with pembrolizumab is the standard treatment for patients with advanced NSCLC, but its efficacy is uncertain in patients with RET gene translocations. We therefore compared the two therapies to determine which treatment is more effective when used first-line.
The study included 261 patients from 23 countries who had advanced NSCLC with RET gene translocation between March 2020 and August 2022. These patients were randomly assigned to the treatment or control groups. With randomization, the researchers can be more confident that any difference observed in the results is due to the treatment being studied and not to pre-existing differences between the groups.
The results showed that patients who received selpercatinib had a significant gain in cancer progression-free survival, reaching 24.8 months, compared to 11.2 months in the control group.
The researchers also evaluated the effectiveness of the drugs on intracranial lesions, as many patients with advanced NSCLC can develop metastases in the brain. At the start of the study, 42 patients with brain metastases were identified. Selpercatinib was able to treat existing metastases in the central nervous system and prevent the formation of new intracranial metastases. This finding is relevant since the treatment of brain metastases is a challenge due to the presence of the blood-brain barrier, which prevents the action of most cancer drugs on lesions in the brain.
Another point evaluated was the safety of the treatment. Patients treated with selpercatinib had adverse effects that differed from chemotherapy, including increased liver enzymes, which were controlled after dose adjustment, and hypertension.
The authors highlighted the importance of performing molecular tests at the time of diagnosis to enable the most appropriate choice of first-line therapy for this patient population.
"This study represents the importance of the appropriate selection of treatment for lung cancer patients according to the molecular characteristics of the tumor. Through the use of precision medicine, it is possible to obtain better results as demonstrated by this study. In addition, the participation of our center reinforces the quality of research in Brazil and the possibility of including Brazilian patients in international clinical studies," says Dr. Milena Mak.
END
IDOR participated in a study evaluating selpercatinib for the treatment of non-small cell lung cancer
The study evaluated the efficacy and safety of the drug in patients with RET gene translocation
2024-01-05
ELSE PRESS RELEASES FROM THIS DATE:
Novel compound protects against infection by virus that causes COVID-19, preliminary studies show
2024-01-05
Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows. Based on the findings, researchers have launched a human clinical trial of one such compound made by chemically stabilizing a key coronavirus peptide.
If the compound, called a stapled lipopeptide, proves effective as a nasal spray in the trial, it could be the basis for a new drug modality to prevent or treat COVID-19, say the authors of the study, posted online today in the journal Nature ...
Speech Accessibility Project begins recruiting people with ALS
2024-01-05
The Speech Accessibility Project has expanded its recruitment and is inviting U.S. and Puerto Rican adults living with amyotrophic lateral sclerosis to participate.
Those interested in participating can sign up online.
Funded by Big Tech companies Amazon, Apple, Google, Meta, and Microsoft, the University of Illinois Urbana-Champaign aims to train voice recognition technologies to understand people with diverse speech patterns and disabilities.
The project began recruiting people with Parkinson’s disease last ...
UofL study shows nicotine in e-cigarettes may not be harmless, as some claim
2024-01-05
With the start of a new year, smokers and vapers may have resolved to quit or cut back on the habit to improve their health. They may want to use caution, however, if their strategy involves switching from cigarettes to e-cigarettes, considered by some to be a less harmful alternative.
A new study from the University of Louisville shows the nicotine in certain types of e-cigarettes may be more harmful than others, increasing risk for irregular heartbeat, or heart arrhythmias.
A popular claim is that nicotine in ...
Maternal diabetes and overweight and congenital heart defects in offspring
2024-01-05
About The Study: This study of 620,000 children found that maternal type 1 diabetes was associated with increased risk for most types of congenital heart defects in offspring, while obesity and overweight were associated with increased risk for complex defects and outflow tract obstruction and decreased risk for ventricular septal defects. These different risk profiles of type 1 diabetes and overweight and obesity may suggest distinct underlying teratogenic mechanisms.
Authors: Riitta Turunen, M.D., Ph.D., and Emmi Helle, M.D., ...
Evaluation of changes in prices and purchases following implementation of sugar-sweetened beverage taxes across the US
2024-01-05
About The Study: Sugar-sweetened beverage (SSB) taxes in Boulder, Colorado; Philadelphia, Oakland, San Francisco, and Seattle led to substantial, consistent declines in SSB purchases following price increases associated with those taxes. Scaling SSB taxes nationally could yield substantial public health benefits.
Authors: Scott Kaplan, Ph.D., of the U.S. Naval Academy in Annapolis, Maryland, is the corresponding author.
To access the embargoed study: Visit our For The Media website ...
The evolution of photosynthesis better documented thanks to the discovery of the oldest thylakoids in fossil cyanobacteria
2024-01-05
Researchers at the University of Liège (ULiège) have identified microstructures in fossil cells that are 1.75 billion years old. These structures, called thylakoid membranes, are the oldest ever discovered. They push back the fossil record of thylakoids by 1.2 billion years and provide new information on the evolution of cyanobacteria which played a crucial role in the accumulation of oxygen on the early Earth. This major discovery is presented in the journal Nature.
Catherine Demoulin, Yannick Lara, Alexandre Lambion and Emmanuelle Javaux from the Early Life Traces & Evolution laboratory of the Astrobiology Research ...
Hypertension's hidden hand: pressure-driven foam cell formation revealed as key driver of arterial disease, paving the way for new therapies
2024-01-05
A new study in Advanced Science unlocks the secrets of how high blood pressure (hypertension) fuels the progression of arterial disease. Led by Professor Thomas Iskratsch, Professor of Cardiovascular Mechanobiology & Bioengineering at Queen Mary University of London, the research team exposes a novel mechanism by which elevated pressure transforms muscle cells in the arterial wall into "foam cells" – the building blocks of plaque buildup that cripples arteries.
The study focuses on vascular smooth muscle cells (VSMCs), the workhorses responsible for maintaining blood vessel tone and flow. Under ...
NRL researchers receive Defense Manufacturing Technology Achievement Award
2024-01-05
WASHINGTON – U.S. Naval Research Laboratory (NRL) researchers, Kevin Cronin and Drew Rodgers, receive Technology Achievement Award for Lightweight Hydrogen Fuel Cells for Unmanned Aerial Systems (UAS) research efforts at Defense Manufacturing Conference held in Nashville, Tenn., Dec. 11, 2023.
The Department of Defense (DOD) has a critical need for increased power and endurance for persistent Intelligence, Surveillance and Reconnaissance (ISR) and transmission of radio frequency (RF) sources for communications and targeting.
“It ...
Applications open for School of Advanced Science on Technology and Innovation Strategies and Policies for Economic Development
2024-01-05
The São Paulo Advanced School on Technology & Innovation Strategies and Policies for Economic Development will be held from June 24 to July 05, 2024, at the University of Campinas (UNICAMP) in São Paulo state, Brazil.
Reporters are invited to register for the scientific sessions and short courses, which will present state-of-art science and results of new research.
The School provides an opportunity to learn about and debate recent developments in the economics of technological change and in science, technology and innovation (ST&I) policy studies. The programme comprises numerous seminars, intensive courses, and roundtable discussions focusing ...
Ancestors of primates lived in pairs
2024-01-05
A study carried out by CNRS1 scientists working with an international team has revealed that around 70 million years ago, when dinosaurs existed, the ancestors of primates most commonly lived in pairs. Only 15% of them opted for a solitary lifestyle. This discovery — that our ancestors adopted variable forms of social organization — challenges the hitherto commonly accepted hypothesis that at the time of dinosaurs, the ancestors of primates lived alone, and that pair living evolved much later. Most likely, pair living offered significant benefits, such as easier reproduction and reduced costs of thermoregulation by huddling in pairs.
While several studies have already been conducted ...
LAST 30 PRESS RELEASES:
Osteoporosis treatment benefits people older than 80
Consuming more protein may protect patients taking anti-obesity drug from muscle loss
Thyroid treatment may improve gut health in people with hypothyroidism
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
High blood sugar may have a negative impact on men’s sexual health
Emotional health of parents tied to well-being of children with growth hormone deficiency
Oxytocin may reduce mood changes in women with disrupted sleep
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes
CTE and normal aging are difficult to distinguish, new study finds
Molecular arms race: How the genome defends itself against internal enemies
Tiny chip speeds up antibody mapping for faster vaccine design
KTU experts reveal why cultural heritage is important for community unity
More misfolded proteins than previously known may contribute to Alzheimer’s and dementia
“Too much going on”: Autistic adults overwhelmed by non-verbal social cues
What’s driving America’s deep freezes in a warming world?
A key role of brain protein in learning and memory is deciphered by scientists
Heart attacks don’t follow a Hollywood script
Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories
Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds
Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%
Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR
New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications
[Press-News.org] IDOR participated in a study evaluating selpercatinib for the treatment of non-small cell lung cancerThe study evaluated the efficacy and safety of the drug in patients with RET gene translocation